Filling the need for trusted information on national health issues…

Drug Resistance

  • Your Selections:

Refine Results

date

Tags

WHO’s New Treatment, Testing Recommendations For Drug-Resistant TB ‘Offer Hope’

Huffington Post: A Turning Point in the Battle Against Drug-Resistant Tuberculosis Ariel Pablos-Mendez, assistant administrator for global health and child and maternal survival coordinator at USAID, and Mario Raviglione, director of the WHO Global TB Program “…[T]wo new recommendations [on multidrug-resistant tuberculosis (MDR-TB)] from WHO offer hope. The first, on…

New WHO Guidelines Recommend Shorter Treatment Regimen For Drug-Resistant TB

BBC News: Shorter treatment ‘will help tackle’ drug-resistant TB “New international guidelines aim to halve the cost and time for treating multi-drug resistant tuberculosis (MDR-TB). The advice from the World Health Organization (WHO) should reduce treatment to around nine months…” (Dreaper, 5/12). The Guardian: WHO recommends shorter drug regimen for…

Nations Ponder Financial Incentives To Spur New Antibiotic Research, Development

The Lancet: Countries mull over incentives for developing antibiotics “The prospect of slipping into a deadly, post-antibiotic era is prompting countries across the world to work out when and what they are willing to pay drug companies to develop desperately needed antibiotics. Governments have commissioned academics, economists, business analysts, and…

USDA To Provide $6M For Research Into Antimicrobial Resistance

CIDRAP News: USDA offers $6 million for antimicrobial resistance research “The U.S. Department of Agriculture (USDA) [Monday] announced the availability of $6 million for research on antimicrobial resistance in agriculture, including how resistance develops and spreads and how to combat it…” (Roos, 5/3).

Governments Should Adopt New Model For Antibiotic Development, Access

Project Syndicate: Overcoming Market Obstacles to New Antibiotics Jim O’Neill, commercial secretary to the U.K. Treasury, honorary professor at Manchester University, visiting research fellow at Bruegel, and chair of the Review on Antimicrobial Resistance “…In the field of antibiotics development, … the divergence between profit-seeking behavior and the public good…

Reforms, Partnerships Critical To Addressing Malaria Drug Resistance

Huffington Post: A Race Against Time to Check Malaria Resistance Philippe Douste-Blazy, under-secretary general of the U.N. and chair of UNITAID “…Urgent reforms as well as stronger partnerships can ensure that new products [to control malaria] reach those in need, at prices that are affordable. … The threat of insecticide…

Sustained Funding, Strong Partnerships Critical To Preventing Drug-Resistant Malaria

Friends of the Global Fight Blog: The Emerging Risk of Drug Resistant Malaria Maile Young, communications intern at Friends of the Global Fight Against AIDS, Tuberculosis and Malaria, discusses malaria parasitic resistance to artemisinin-based combination therapies (ACTs) in the Greater Mekong Subregion, which “could have potentially devastating consequences for the…

The Henry J. Kaiser Family Foundation Headquarters: 2400 Sand Hill Road, Menlo Park, CA 94025 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/KaiserFamFound

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in Menlo Park, California.